Skip to content

effect of ketamine on controlling pain after total knee arthroplasty

comparison of the Effectiveness of pre-operative intravenous ketamine administration with placebo in controlling post-operative pain in patients with advanced knee osteoarthritis undergoing total knee arthroplasty

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220315054298N1
Enrollment
60
Registered
2022-04-27
Start date
2022-06-01
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of knee. Unilateral primary osteoarthritis of knee

Interventions

Intervention 1: Intervention group: 0.5 miligram per kilogram of body weight ketamine in 5 cc syringe and increase to total volume of 5ml with normal saline. after spinal anesthesia and before incisi

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Between 18 and 85 years old undergoing unilateral, primary total knee arthroplasty "TKA" for degenerative end-stage osteoarthritis(OA) of the knee (score of >2 on Kellgren-Lawrence scale).

Exclusion criteria

Exclusion criteria: patients who refuse to participate, classified as ASA IV or V by the American Society of Anesthesiologists, body mass index greater than 40 kg/m2, rheumatoid arthritis, contraindication or allergy to opioid pain medications allergy to amide or sulpha anesthetics, unable to understand the visual analog scale (VAS) , any preoperative ketamine or chronic narcotic usage (>10mg systemic morphine equivalents daily ) as it causes opioids tolerance , those who are discharged before the first 24 hours postoperatively, previous history of knee arthroplasty, prior surgery on the ipsilateral knee within 6 months, simultaneous bilateral arthroplasty, the patients receiving general anesthesia or a nerve block patients with an ejection fraction of less than 30%, creatinine clearance of less than 30mL/min, chronic liver disease, any neurologic or psychiatric disorder (including bipolar,post-traumatic stress disorder, schizophrenia), chronic alcohol abuse

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 2 hour , 6hour , 12 hour ,24 hour ,10 days ,42 days post operative. Method of measurement: Visual Analogue Scale.

Secondary

MeasureTime frame
Maximum post op knee flexion. Timepoint: at discharge ,post op day 10 , post op day 42. Method of measurement: orthopedic ruler.;Hospital stay duration. Timepoint: from the end of operation to discharge time. Method of measurement: time-hour.;Time of first morphine request. Timepoint: from the end of operation to first time of morphine request. Method of measurement: time-hour.;Total morphine(analgesics) consumption. Timepoint: at the time of discharge. Method of measurement: mg/kg....patient document.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSina Javidmehr

Tehran University of Medical Sciences

sinajavidmehr@gmail.com+98 21 8490 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026